Join to view full profile
2959 Sharpsburg McCullum RdNewnan, GA 30265
Phone+1 770-502-2000
Fax+1 770-502-2049
Dr. Stark is on Doximity
As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
Emory University School of MedicineFellowship, Rheumatology, 2006 - 2008- Emory University School of MedicineResidency, Internal Medicine, 2003 - 2006
Vanderbilt University School of MedicineClass of 2003
Certifications & Licensure
GA State Medical License 2006 - 2027
American Board of Internal Medicine Internal Medicine- American Board of Internal Medicine Rheumatology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory - Core EMR, Epic Systems Corporation, 2013
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2013
- Fellow (FACR) American College of Rheumatology
Publications & Presentations
PubMed
- Challenges and Opportunities in Psoriatic Disease: An Integrated View of the Future.Lyn Chinchay, Kaiyang Song, Jeffrey Stark, Nicole L Ward, Iain B McInnes
The Journal of Rheumatology. 2025-12-01 - Certolizumab Pegol Treatment in Patients With Crohn's Disease: Final Safety Data From the SECURE Registry.Gary R Lichtenstein, Scott D Lee, Brian G Feagan, Edward V Loftus Jr, Samson Ng
Crohn's & Colitis 360. 2025-01-01 - 5 citationsImpact of Disease Burden of Patients with Psoriasis on Biologic Therapy Switching: Real-World Evidence from the CorEvitas Psoriasis Registry.Andrew Blauvelt, Robert R McLean, Silky W Beaty, Adam P Sima, Robert Low
Dermatology and Therapy. 2024-10-01
Press Mentions
UCSF-Led Study Aims to Improve Treatment of Painful Skin DiseaseDecember 20th, 2024- Non-Radiographic Axial Spondyloarthritis Recognized with ICD-10 CodeAugust 21st, 2020
- UCB Announces U.S. Availability of BIMZELX® for the Treatment of Adults with Moderate-to-Severe Plaque PsoriasisNovember 16th, 2023
Professional Memberships
- Fellow
Industry Relationships
- Head of Medical Affairs, Rheumatology, UCB, Inc.2014 - Present
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: